Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

aquarium muenster pahlsmeier gmbh - ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh), acriflavine hydrochloride (unii: 1s73vw819c) (acriflavine - unii:1t3a50395t), methyl orange (unii: 6b4tc34456) (methyl orange - unii:6b4tc34456) - ethacridine 4 mg in 1 ml - no known contraindications or side effects. should you notice side effects in your ornamental fish, please inform your vet or pharmacist. take unused medical products and unfinished containers of medical products to the designated collection points. date of last revision of package insert 2014-09-10

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

aquarium muenster pahlsmeier gmbh - malachite green oxalate (unii: gy1h9o33vu) (malachite green cation - unii:awt9r95tv1), ethacridine lactate (unii: v5il571c1t) (ethacridine - unii:wix85m1a6r), methylene blue anhydrous (unii: 8nap7826ub) (methylene blue cation - unii:zmz79891zh), gentian violet (unii: j4z741d6o5) (gentian violet cation - unii:3gvj31t6yy) - malachite green oxalate 1.25 mg in 1 ml - none known. should you notice side effects in your ornamental fish, please inform your vet or pharmacist. take unused medical products and unfinished containers of medical products to the designated collection points.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - 61248 - perioperative methylene blue stain - the device is intended to be used in surgery for the marking of tissues and surgical findings and to test the tightness of urinary tract sutures and colorectal sutures.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - 61248 - perioperative methylene blue stain - the device is intended to be used for the marking of tissues for surgical findings, for intra-operative lymphatic mapping and to test the tightness of urinary tract sutures and colorectal sutures

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - patent blue v, quantity: 25 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; dibasic sodium phosphate dodecahydrate - colours the lymph vessels so that they can then be injected with an x-ray contrast medium

Танзанија - Енглески - Tanzania Medicinces & Medical Devices Authority

inqaba biotec east africa limited, tanzania - laboratory reagent -

Европска Унија - Енглески - EMA (European Medicines Agency)

provepharm sas - methylthioninium chloride - methemoglobinemia - all other therapeutic products - acute symptomatic treatment of medicinal and chemical products- induced methaemoglobinaemia.methylthioninium chloride proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

method pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 81 mg - uro-458 tablets is indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uro-458 tablets is contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

biocomp pharma, inc. - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyophen ® tablets are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. hypersensitivity to any of the ingredients is possible. risk benefits should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis, acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy). a dependence on the use of hyophen ® tablets has not been reported and due to the nature of its ingredients, abuse of hyophen ® tablets is not expected.

Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

buckman laboratories pty ltd - methylene bis(thiocyanate) - unknown - methylene bis(thiocyanate) cyanide active 0.0 - active constituent